Phased regulation essential for valuation says new European diagnostics group
This article was originally published in RAJ Devices
Executive Summary
Diagnostics development needs to have clear regulatory milestones akin to the pre-clinical and Phase I, II and III stages of drug development, says the co-ordinator of a new European group of small diagnostics companies launched on 30 September1.